In conclusion, we propose the immunohistochemical determination of the protein expression of pERK and nuclear p53 as potential prognostic biomarkers in resected adenocarcinoma and squamous cell lung carcinoma tumors, respectively. This evidence concerns the gene EIF2AK3 and adenocarcinoma.